Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/16/06  and contains information from public web pages.

Dr. Mark A. Babizhayev

Wrong Dr. Mark A. Babizhayev?

Senior Research Investigator

Moscow Helmholtz Research Institute of Eye Diseases
 
Background

Employment History

  • Helmoltz Research Institute for Eye Diseases

Education

  • PhD
  • Ph.D. , Biophysics and Pathophysiology
  • Ph.D
7 Total References
Web References
Anti Aging Conference - Preventative Health Care
www.antiageingconference.com, 16 Sept 2006 [cached]
Dr Mark A Babizhayev PhD Executive Director of Innovative Vision Products, Inc., Delaware (USA). Senior Research Investigator at Moscow Helmholtz Research Institute of Eye Diseases (RF). Scientific Consultant to Exsymol SAM, Monte Carlo (MC).
...
Dr Mark A Babizhayev
The breakthrough behind Can-C and the ...
vita-stream.com [cached]
The breakthrough behind Can-C and the introduction of n-acetylcarnosine eye drops took place in the early 1990s, with landmark research by the bio-physicist Dr Mark Babizhayev and a Russian research team. Human trials on cataract sufferers, involving a twice daily dose of NAC formulated drops over a period of six months, produced remarkable results. The research revealed that: •88.9 per cent of patients had improved glare sensitivity (which is a general decline in the sharpness of objects and surroundings -things literally becoming a bit fuzzy around the edges); •90 per cent reported improved visual acuity - clearer and sharper vision; •Perhaps most significantly, in that cataracts are characterised by a clouding of the eye lens, 41 per cent of patients experienced a significant improvement in lens 'transmissivity'. And while the patients were taking the NAC carnosine eye drops, Dr Babizhayev noted that there was no recurrence of cataract development. He further reported that drug tolerance was good - there were no side effects, based on the dosage of 1% NAC.
...
Can-C's formula is the one perfected and patented by Dr Babizhayev and his team - who tried, tested and rejected many other forms of carnosine during their extensive research.
...
It is Dr. Babizhayev's assertion that certain substances, including vitamins A and E inhibit the conversion process of the NAC into L-carnosine INSIDE the aqueous humor of the eye. He does not endorse them - rather the opposite (at least when used topically, however if vitamin A or E are taken orally there is no contraindication).
...
Can-C eye-drops have been recommended by the inventors (IVP) and Dr. Mark Babizhayev has suggested that it is a useful adjunct in the condition of open angle glaucoma.
...
Extensive research by Can-C pioneer Dr. Mark Babizhayev, respected for his work at the Helmoltz Research Institute for Eye Diseases in Moscow, began in 1991.
...
Commenting on the research, Dr. Babizhayev said: "For most patients treated, drug tolerance was good and no side effects were specifically associated with the application of 1 percent NAC.
Anti Aging Conference - Preventative Health Care
www.antiageingconference.com, 10 Aug 2006 [cached]
Dr Mark A Babizhayev PhD Executive Director of Innovative Vision Products, Inc., Delaware (USA). Senior Research Investigator at Moscow Helmholtz Research Institute of Eye Diseases (RF). Scientific Consultant to Exsymol SAM, Monte Carlo (MC).Executive Director of Innovative Vision Products, Inc., Delaware (USA). Senior Research Investigator at Moscow Helmholtz Research Institute of Eye Diseases (RF). Scientific Consultant to Exsymol SAM, Monte Carlo (MC).
Dr. Babizhayev who headed the ...
www.vita-stream.com [cached]
Dr. Babizhayev who headed the Russian research team (Innovative Vision Products) that developed this innovative treatment, has stated that the maximum obtainable results are usually achieved in a 3 to 5 month period, however there are often noticeable benefits within only 1-month.
...
Pioneered by respected bio-physicist Dr Mark Babizhayev and a team of Russian researchers in the early 1990s, Can-C eye drops contain a potent anti-ageing and anti-oxidant known as N-acetylcarnosine, or NAC for short.
...
Extensive research by Can-C pioneer Dr Mark Babizhayev, respected for his work at the Helmoltz Research Institute for Eye Diseases in Moscow, began in 1991.
...
Commenting on the research, Dr Babizhayev said: "For most patients treated, drug tolerance was good and no side effects were specifically associated with the application of 1 per cent NAC.
...
The Can-C NAC formula has been painstakingly perfected by Dr Babizhayev and the team at Innovative Vision Products.
Can-C eye drops for the reversal of cataracts
www.antiageing-nutrition.com, 4 Jan 2012 [cached]
Pioneered by respected bio-physicist Dr Mark Babizhayev and a team of Russian researchers in the early 1990s, Can-C eye drops contain a potent anti-ageing and anti-oxidant known as N-acetylcarnosine, or NAC for short.
...
Extensive research by Can-C pioneer Dr Mark Babizhayev, respected for his work at the Helmoltz Research Institute for Eye Diseases in Moscow, began in 1991.
...
Commenting on the research, Dr Babizhayev said: "For most patients treated, drug tolerance was good and no side effects were specifically associated with the application of 1 per cent NAC.
...
The Can-C NAC formula has been painstakingly perfected by Dr Babizhayev and the team at Innovative Vision Products.
...
Dr. Babizhayev who headed the Russian research team (Innovative Vision Products) that developed this innovative treatment, has stated that the maximum obtainable results are usually achieved in a 3 to 5 month period, however there are often noticeable benefits within only 1-month.
Other People with the name "Babizhayev":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.